Osteoarthritis drug of past could help treat opioid addiction Medical Dialogues Bureau28 Feb 2018 7:15 PM ISTResearchers at Linda and Jack Gill Center for Biomolecular Science at IU Bloomington in a new study have discovered that a drug previously tested to...
Erenumab-Latest preventive treatment for migraine approved Vinay Singh singh17 May 2018 8:00 PM ISTAimovig (erenumab-aooe) is the new drug that is given by once-monthly self-injections for the preventive treatment of a migraine in adults.It is the...
Tanezumab Novel drug for improving pain in Osteoarthritis Vinay Singh singh23 July 2018 8:28 PM ISTA 16-week Phase 3 study (A4091056) in patients with osteoarthritis (OA) pain evaluating the subcutaneous administration of tanezumab, an...
Nasal Glucagon equally effective for hypoglycemia in Diabetes Medha Baranwal Baranwal31 Oct 2018 7:15 PM ISTAn investigational nasal glucagon showed similar effectiveness in the treatment of hypoglycemia in type 1 diabetes (T1D) as compared to the currently...
Lasmiditan may be new treatment for acute Migraine Vinay Singh singh18 Nov 2018 8:10 PM ISTLasmiditan may be the new treatment for an acute Migraine as FDA has received a request called New Drug Application for approval.Eli Lilly has...
Empagliflozin gets FDA Fast-Track status for Chronic Heart Failure Treatment Deepanjana Sarkar28 Jun 2019 7:30 PM ISTThe U.S Food and Drug Administration has tagged sodium-glucose co-transporter 2 (SGLT2) inhibitor Empagliflozin with Fast-Tracked designation for the...
Baricitinib effective for treating moderate to severe atopic dermatitis, reveal clinical trial results Medha Baranwal Baranwal2 Sept 2019 7:30 PM ISTBaricitinib, an oral JAK inhibitor, has met its primary endpoint for the treatment of moderate to severe atopic dermatitis (AD) in adults, in...
Baricitinib found efficacious in atopic dermatitis in phase 3 trials Deepanjana Sarkar5 Feb 2019 7:20 PM ISTAccording to a recent report, Eli Lilly and Company and Incyte Corporation has announced that Baricitinib has been found efficacious and safe in...
Cholesterol drug Anacetrapib cuts heart risk by 9 pct : NEJM Anjali Nimesh Nimesh2 Oct 2017 9:00 AM ISTA large study of Merck & Co Inc's experimental cholesterol drug anacetrapib found that it cut the risk of heart attack and death by a modest 9...
